Beaumont Financial Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Beaumont Financial Advisors's LLY Position: Q2 2026 in Review
Beaumont Financial Advisors increased its Eli Lilly (LLY) stake by 1.7% in Q2 2026, buying an estimated $80.7K and bringing the position to 4,760 shares worth $5.71M. The position accounts for 0.36% of the portfolio, ranked #56.
Beaumont Financial Advisors first reported a position in LLY in Q3 2019 and has held it in 28 quarters since. 4,635 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Beaumont Financial Advisors held 4,760 shares of Eli Lilly worth $5.71M as of Q2 2026.
- Beaumont Financial Advisors bought 79 Eli Lilly shares in Q2 2026, an estimated $80.7K.
- Eli Lilly made up 0.36% of Beaumont Financial Advisors's portfolio in Q2 2026, its #56 holding.
- Beaumont Financial Advisors first reported a position in Eli Lilly in Q3 2019 and has held it in 28 quarters since.
- 4,635 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Beaumont Financial Advisors's 13F filing for Q2 2026, filed 4 Aug 2026.